FDA Updates With Agency Leadership: Removing Black Box Warnings for HRT Part 1

‘Learn more about why the FDA is initiating label changes for hormone replacement therapy products for menopausal women.’

*The opinions expressed by the hosts and guests in this show are not necessarily the views of Children’s Health Defense.

Related Videos

FDA Updates With Agency Leadership: Removing Black Box Warnings for HRT Part 2

HHS Announces Efforts to Advance Women's Health

CHD Lawsuits & FDA Warnings + Exclusive Interview With Robert O. Young